A new form of hereditary ataxia with defective vestibular function was reported recently by Philcox et al. (1975) . It has several features which distinguish it from that previously describednotably, defective optokinetic nystagmus and abnormal or absent oculovestibular responses in all affected patients. The first symptom is usually unsteadiness of gait, intermittent in the early stages, but progressive over several years to total incapacity. This is associated with hypertonicity, hyperreflexia, and dysarthria which progresses to the extent that speech often becomes unintelligible. There is usually no sensory deficit. Most severely affected patients have intellectual impairment. First symptoms appear between the ages of 20 and 52 years.
The problem arose during management of this family of finding a method for identifying affected individuals before the disease expressed itself clinically. This has important implications for genetic counselling since the condition may not become apparent until after it has been transmitted to the next generation. We set out to detect sensitisation in affected individuals, and followed this by looking for it in clinically normal children, some of whom would be expected to develop the disease later in life. These findings may be the first demonstration of sensitisation to components of nervous tissue preceding the onset of clinically apparent neurological disease. They could have important implications for the pathogenesis of this and other chronic diseases such as Huntington's chorea and multiple sclerosis.
Subjects and methods
Seven of the nine severely affected individuals in this family were studied, as well as 24 of their 29 children, all of whom were asymptomatic and normal on examination. Ages of the children ranged from 8 to 32 years. Of the five children not tested, one was known to be affected, another had died from unknown causes at a young age, and the remaining three could not be traced, or refused to undergo investigation. Nineteen healthy medical and laboratory staff between 20 and 45 years of age acted as control subjects, some of them on several occasions.
ANTIGEN PREPARATION
Antigen was prepared by homogenisation of fresh whole rat brain in a ground glass tissue homogeniser. A 1 % w/v suspension was made up in medium 199 (GIBCO) with 0.3 g/100 ml tris buffer (Fluka) Sensitisation to rat brain antigen was also studied in affected individuals by passive haemagglutination (Ling, 1961) and by indirect immunofluorescence using frozen sections of rat brain as substrate (Edgington and Dalessio, 1970 (Rocklin et al., 1971; Alvord et al., 1974) , and encephalitis (Behan et al., 1968; Nyerges et al., 1974) . Such an issue is almost impossible to resolve in diseases like multiple sclerosis and GuillainBarre syndrome because it cannot be predicted which individuals will develop the disease at some future time. Sheremata et al. (1975) (Waksman and Adams, 1955; Paterson, 1966) and in multiple sclerosis and the Guillain-Barre syndrome in man. However, we are not aware that hypersensitivity has been demonstrated in normal subjects who may be expected to develop disease in the future. Being dominantly inherited, about half of first generation children in this family might be expected to develop the illness. Our finding of abnormal results in eight out of 24 children is consistent with this ratio when allowance is made for the small size of the sample and the fact that five children, at least one of whom is known to be affected, could not be examined.
Leucocyte migration inhibition is regarded as a reliable in vitro index of sensitisation to a variety of antigens in man (S0borg and Bendixen, 1967; Ramsay et al., 1976) . Leucocyte migration may be stimulated in conditions of low antigen concentra-tion (Nelson, 1969) and lesser sensitivity of cells (S0borg, 1971) . S0borg (1971) 
